Come up with a name for your new list and we'll add to it:
AiVita Biomedical raised a round of funding on July 17, 2018. Investors include
California Institute for Regenerative Medicine.
AiVita Biomedical is advancing commercial and clinical-stage programs utilizing curative and regenerative medicines. Built upon expertise in stem cell growth and directed, high- purity differentiation…